nach oben

Reactions Weekly

Erschienen in:

01.06.2023 | Case report

Tozinameran

New or worsening neurological symptoms, muscle pain and walking difficulties: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Lotan I, et al. Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel. European Journal of Neurology 28: 3742-3748, No. 11, Aug 2021. Available from: URL: http://doi.org/10.1111/ene.15028

Titel: Tozinameran
New or worsening neurological symptoms, muscle pain and walking difficulties: 3 case reports
Publikationsdatum: 01.06.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41246-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Tozinameran

New or worsening neurological symptoms, muscle pain and walking difficulties: 3 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Loperamide/octreotide/trametinib

Advice on safe use of DOACs in children and patients with renal impairment

Antivirals/foscarnet/thalidomide

Multiple drugs

Adalimumab/infliximab/vedolizumab

Antineoplastics